VSI gets Lockheed Martin order

Separately, Elbit denied reports in the Turkish press Tuesday that the Turkish government foreclosed a $10m. guarantee on a spy systems deal the two signed in 1999.

By AVI KRAWITZ
March 8, 2006 07:22

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Vision Systems International, LLC, a subsidiary of Elbit Systems, received an $84.6 million follow on order from Lockheed Martin for pilot flight gear, as part of the system Development and Demonstration phase of Lockheed's F-35 fighter aircraft program. The deal follows a 2003 order, bringing the combined value to $156m. The helmet mounted displays, which include oxygen mask and chemical/biological hazard protection, will be supplied to all Lockheed's F-35 customers. Separately, Elbit denied reports in the Turkish press Tuesday that the Turkish government foreclosed a $10m. guarantee on a spy systems deal the two signed in 1999.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS